Skip to main content
Premium Trial:

Request an Annual Quote

Otherwise Similar

The SARS-CoV-2 strain recently identified in the UK appears to be more easily transmitted, but otherwise is fairly similar to other viral strains, the New York Times writes.

Last month, officials in the UK reported finding a new viral strain, called B.1.1.7, in southern England that appeared to be spreading more easily, and it has since been spotted across the world in Australia, Canada, South Korea, and the US.

As the Times notes, recent analyses suggest B.1.1.7 is more transmissible — one recent analysis has suggested that it may be 56 percent more transmissible. There are some hints, the Times writes, that the strain may lead to a higher viral load among infected people, which it says could fuel the strain's easier spread, but it adds more work is needed. 

"We need to look at this evidence as preliminary and accumulating," the University of St. Andrews's Muge Cevik tells it.

The Times adds that B.1.1.7 doesn't lead to more severe disease or increased deaths than other SARS-CoV-2 strains 

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.